- Joined
- 13 August 2006
- Posts
- 897
- Reactions
- 1,136
I agree WES is looking expensive, but if it's "way too expensive" to put in a buy order, why is it ok to buy through the dividend reinvestment scheme?way too expensive currently for me to add to the holding ( except via the DRP )
well i think the price will trend down with the overall market in timeI agree WES is looking expensive, but if it's "way too expensive" to put in a buy order, why is it ok to buy through the dividend reinvestment scheme?
No matter what WES is a powerhouse company and for those that are holding should be laughing all the way to the bank.well i think the price will trend down with the overall market in time
i am hoping WES will either divest Office-Works or spin off a property trust similar to BWP
so , so far it is worth my while to slowly accumulate and the DRP increase isn't 'sheep stations currently ( i reduced the holding April last year )
and any useful WES order would several magnitudes larger than my DRP allotment
however it is about time i decide which DRP participations i should cancel and just use the cash generally ( invest/pay bills etc.)
i decided to retain a toehold , a major reason for that is i couldn't find a better place to invest the cashI await that time to get back in.
Good move divs I suppose your buy in SP was very light in comparison to the current SP.i decided to retain a toehold , a major reason for that is i couldn't find a better place to invest the cash
Who's losing market share, I would suggest it's the "corner store" pharmacy, they can't compete with the buying power of CW.with Priceline bedding down in the healthcare division of WES, the gorilla in the room is Chemist Warehouse.
Now there's a plan afoot to merge/ back list CW into Mayne Pharma. When MAY reported last week, there was some CW disclosure that emerged.
... "the really impressive numbers from Chemist Warehouse were its margins. At the earnings before interest and tax line, Chemist Warehouse delivered a margin of 18.3 per cent in the December half, sharply up from 16.2 per cent in the prior year.
Let’s put that in some perspective.
"Sigma itself has an EBIT margin of 0.7 per cent, although it should be noted that Sigma makes most of its earnings from wholesaling rather than retailing. Coles’ EBIT margin is 5.1 per cent. Inside Wesfarmers, the Bunnings, Kmart and Officeworks chains have EBIT margins of 12.8 per cent, 9.9 per cent and 5.1 per cent respectively. Woolworths’ EBIT margin is 6.1 per cent, and its Big W discount department store had an EBIT margin of 2.1 per cent.
"Clearly, these are all very different businesses to a franchised pharmacy chain. But the comparisons are not completely out of kilter, given Chemist Warehouse makes about 67 per cent of its sales from what is called the front of the store – that is, not the pharmacy dispensing counter.
CW growth is said to be at 9 per cent while across the sector it's only nudging 3 percent... Who's losing market share?
Why? Officeworks is a good business. Its averaging (over the cycle) a return on capital employed of over 20% as far as I am aware of and it it dominates its category so why would you want to divest it?well i think the price will trend down with the overall market in time
i am hoping WES will either divest Office-Works or spin off a property trust similar to BWP
so , so far it is worth my while to slowly accumulate and the DRP increase isn't 'sheep stations currently ( i reduced the holding April last year )
and any useful WES order would several magnitudes larger than my DRP allotment
however it is about time i decide which DRP participations i should cancel and just use the cash generally ( invest/pay bills etc.)
yes i agree Office-Works is doing very well , and i believe owns some of the property where outlets are situated , however the fate of Office-Works has been discussed several times the WES discussions on the future of WES ( at management level )Why? Officeworks is a good business. Its averaging (over the cycle) a return on capital employed of over 20% as far as I am aware of and it it dominates its category so why would you want to divest it?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?